Optimer Pharmaceuticals logo

Optimer Pharmaceuticals

North America, California, United States, San Diego

Description

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing

Investor Profile

Optimer Pharmaceuticals has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Clinical Trials, Health Care.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Optimer Pharmaceuticals frequently co-invest with?

Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Optimer Pharmaceuticals often collaborate with?

I. Wistar Morris III
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1

What are some of recent deals done by Optimer Pharmaceuticals?

Cempra

Chapel Hill, North Carolina, United States

Cempra develops medicines for the treatment of bacterial infections and chronic illnesses.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series BJul 1, 2007
Amount Raised: $10,000,000